Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1603 of 5804
-
Sound waves vs. bone pain: can ultrasound replace radiation?
Symptom relief OngoingThe FURTHER study aims to evaluate the effectiveness and cost-effectiveness of MR-HIFU (alone or in combination with EBRT) compared to EBRT alone, the standard-of-care, as a palliative treatment option to relieve CIBP. The FURTHER study consists of a multicenter, three-armed rand…
Phase: NA • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Free genetic testing offered to 27,500 people to find hidden cancer risks
Knowledge-focused Recruiting nowThis trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general public. Researchers hope to learn the value of providing broad, public-wide testing for high risk cance…
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New study tests if a gentler therapy can match exposure therapy for PTSD
Symptom relief Recruiting nowThe purpose of this study is to compare two kinds of therapy for Posttraumatic Stress Disorder (PTSD): exposure therapy (ET) and Interpersonal Psychotherapy (IPT). The results of this study will allow us to see if IPT and ET are equally effective in treating PTSD due to Military …
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New combo therapy aims to tame kidney disease
Disease control Recruiting nowThe primary objective of this study is to evaluate the effectiveness of belimumab and intravenous rituximab co-administration at inducing a complete or partial remission (CR or PR) compared to rituximab alone in participants with primary membranous nephropathy. Background: Prim…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New study tests best statin dose for seniors to prevent heart attacks
Prevention Recruiting nowOne of the most effective drug in the primary prevention of cardiovascular disease is statins. The protective effects of statin on developement of cardiovascular disease has been demonstrated in elderly individuals. Since side effects of statin are more common in elderly individu…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
New antibody takes on Hard-to-Treat cancers
Disease control OngoingPart 1 will be a dose escalation study of IV ICT01 (a monoclonal antibody targeting BTN3A) as monotherapy in patients with advanced solid or hematologic tumors, followed by a cohort examining the combination of ICT01 plus pembrolizumab (Keytruda). Part 2 will be a cohort expansio…
Phase: PHASE1, PHASE2 • Sponsor: ImCheck Therapeutics, an Ipsen company • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Brain implant study aims to cut seizures in epilepsy patients
Disease control TerminatedThe purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction in newly implanted participants through 3 years of follow-up.
Phase: NA • Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Sugar pill or savior? supplement may cut insulin use in pregnancy diabetes
Disease control OngoingGestational diabetes mellitus (GDM) is defined as hyperglycemia first-diagnosed during pregnancy. Glycemic control reduces GDM-related complications. With the new diagnostic criteria of GDM, up to 25% of pregnant women have GDM, whereas it was previously 6-10% in France. Therefor…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope: drug may shield brain from CAR T-Cell therapy side effects
Disease control TerminatedThis phase II trial studies how well anakinra works in preventing severe chimeric antigen receptor T-cell-related encephalopathy syndrome after chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma that has come back or has not responded to treatment. Im…
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Friendly phone avatar boosts HIV care in young black men
Disease control CompletedThe investigators propose to determine the efficacy of "My Personal Health Guide," a theory-based innovative talking relational human Avatar mobile phone application to engage HIV-positive AAMSM in adherence and retention in care. Providing an empathetic talking Avatar source of …
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New combo injection shows promise for tough head and neck cancers
Disease control CompletedThe purpose of this study is to assess the efficacy and safety of intratumoral (IT) ulevostinag PLUS pembrolizumab (MK-3475) compared to pembrolizumab alone as a first line treatment of adults with metastatic or unresectable, recurrent head and neck squamous cell carcinoma (HNSCC…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Ultra-High-Resolution MRI could sharpen spine surgery planning
Diagnosis Recruiting nowHigh-resolution MRI (7 Tesla) of the spine is capable to differentiate osseous spurs from discus-material and better depict the compressed nerve in the neuroforamen compared to 3T MRI. Provide the surgeon with a detailed high-resolution anatomical image before surgery and potent…
Sponsor: Reto Sutter, MD • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
Moms helping moms: peer program boosts HIV care after birth
Disease control CompletedThe purpose of this study is to test the efficacy of a theory-driven peer intervention for pregnant and postpartum women living HIV. The peer intervention is designed to increase self-efficacy, social support, self-regulatory behaviors, and outcome expectancy in order to improve …
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a cancer pill keep bone sarcomas at bay?
Disease control Recruiting nowRandomized, non-comparative, multicentre exploratory phase II study. Two arms concerning patients with bone sarcoma after the first line therapy: in the first arm, patients will be treated with Regorafenib for a maximum of 12 months as maintenance therapy after first line therap…
Phase: NA • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug shows promise for Long-Term control of ulcerative colitis
Disease control TerminatedThe purpose of this OLE Study D5272C00002 (Legacy #3151-202-008) is to permit participants who previously enrolled in the double-blind Study D5272C00001 (Legacy #3151-201-008) to receive brazikumab, allowing for long-term observation of safety and efficacy in these participants t…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a simple blood test spare thyroid cancer patients from unnecessary radiation?
Disease control Recruiting nowThis trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy
Phase: PHASE3 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Oxygen chamber vs. pills: new hope for Trauma-Linked fibromyalgia?
Disease control CompletedThe investigators have previously studied the efficacy of hyperbaric oxygen therapy (HBOT) as a treatment for Fibromyalgia syndrome (FMS) in a prospective, active control, crossover clinical trial. The results demonstrated significant amelioration of all FMS symptoms, with signif…
Phase: NA • Sponsor: Assaf-Harofeh Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Weight loss and walking: a new hope for PAD patients?
Disease control Recruiting nowThe PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvement or less decline in six-minute walk distance at 12 month follow-up than walking exercise alone in people with PAD and B…
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug shows promise in preventing transplant complications
Disease control CompletedThis is a phase 2 open-label trial designed to evaluate the efficacy of tildrakizumab in improving graft-versus-host disease (GVHD)-free relapse-free survival after myeloablative allogeneic hematopoietic cell transplantation (alloHCT) for hematologic malignancy.
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Emotional stress may be a hidden trigger for repeat heart attacks — a study investigates
Knowledge-focused CompletedThe purpose of this study is to look at the link between emotional stress and heart disease in men and women. Taking part in this study involves one clinic visit, one week of at home monitoring, and follow up phone calls every 6 months for 3 years.
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC